Thalys Medical Technology Group Corporation (SHA:603716)

China flag China · Delayed Price · Currency is CNY
22.12
-0.27 (-1.21%)
Feb 26, 2026, 3:00 PM CST
Market Cap4.56B +261.4%
Revenue (ttm)1.25B -34.2%
Net Income-240.46M
EPS-1.26
Shares Out206.22M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume5,167,700
Average Volume11,162,066
Open22.40
Previous Close22.39
Day's Range22.04 - 22.44
52-Week Range8.10 - 38.12
Beta0.86
RSI42.36
Earnings DateApr 29, 2026

About SHA:603716

Thalys Medical Technology Group Corporation provides medical integrated operation and management services in China. It offers automated immunofluorescence analyzer; coagulation reagent; COVID-19 test kit; line blot1 fully automated immunoblotting instrument; and flow products. The company also provides automated coagulation analyzer; automated immunoassay system; automated biochemical analysis system; automated chemiluminescence immunoassay system; and blood analyzer. The company was formerly known as Thalys Medical Technology Inc. and changed ... [Read more]

Sector Healthcare
Founded 2004
Employees 1,246
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 603716
Full Company Profile

Financial Performance

In 2024, SHA:603716's revenue was 1.81 billion, a decrease of -9.74% compared to the previous year's 2.01 billion. Losses were -209.24 million, 32.0% more than in 2023.

Financial Statements